Potassium iodide in refractory, recurrent pediatric Sweet syndrome: Guidance in dosing and monitoring | Zendy

Tangtatco Jennifer Aileen Ang | Zendy; Ho Nhung | Zendy; Drucker Aaron | Zendy; Forse Catherine | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Potassium iodide in refractory, recurrent pediatric Sweet syndrome: Guidance in dosing and monitoring

Author(s) -

Tangtatco Jennifer Aileen Ang,

Ho Nhung,

Drucker Aaron,

Forse Catherine

Publication year - 2018

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.13391

Subject(s) - medicine , refractory (planetary science) , dosing , iodide , potassium , pediatrics , chemistry , inorganic chemistry , physics , organic chemistry , astrobiology

We describe a 5‐month‐old boy with clinical and histopathologic presentation of Sweet syndrome. He responded to systemic corticosteroids, with multiple flares on tapering; potassium iodide was added, which provided complete resolution of Sweet syndrome. Potassium iodide has been used in only a few cases, and no standard dosage has been established in children. We discuss calculation of a pediatric dosage for potassium iodide in Sweet syndrome.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research